Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily

NCT01147744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone Propionate 100mcg via ACCUHALER/DISKUS
DRUG: GSK2190915 100mg
DRUG: GSK2190915 10mg
DRUG: GSK2190915 300mg
DRUG: GSK2190915 30mg
DRUG: Montelukast 10mg
DRUG: Placebo GSK2190915 one tablet
DRUG: Placebo montelukast
DRUG: Placebo fluticasone propionate via ACCUHALER/DISKUS
DRUG: Placebo GSK2190915 two tablets

Sponsor

GlaxoSmithKline